Dutasteride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Dutasteride
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Dutasteride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

44 API Suppliers, 17 USDMF, 6 CEP/COS, 7 JDMF, 5 EU WC, 25 KDMF, 20 NDC API, 28 Listed Suppliers, $ API Reference Price

44 API Suppliers
17 USDMF
6 CEP/COS
7 JDMF
5 EU WC
25 KDMF
20 NDC API
28 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

148 FDF Dossiers, 25 FDA Orange Book, 66 Europe, 17 Canada, 8 Australia, 3 South Africa, 29 Listed Dossiers

148 FDF Dossiers
25 FDA Orange Book
66 Europe
17 Canada
8 Australia
3 South Africa
29 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 0.5MG, CAPSULE;ORAL - 0.5MG;0.4MG

CAPSULE;ORAL - 0.5MG
CAPSULE;ORAL - 0.5MG;0.4MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Evonik, 2 Rochem International Inc, 7 SPI Pharma, 2 Seqens, 10 DKSH, 3 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 12 Corel Pharma Chem, 2 DFE Pharma, 3 Finar, 8 Gangwal Chemicals, 10 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 17 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 5 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 24 Roquette, 16 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 The Dow Chemical Company, 1 Valens Pharmachem, 1 Vasa Pharmachem, 2 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

62 Coating Systems & Additives, 41 Fillers, Diluents & Binders, 35 Controlled & Modified Release, 28 Thickeners and Stabilizers, 26 Solubilizers, 24 Film Formers & Plasticizers, 20 Parenteral, 20 Topical, 17 Taste Masking, 17 Direct Compression, 14 Granulation, 10 Co-Processed Excipients, 9 Empty Capsules, 9 Disintegrants & Superdisintegrants, 8 Chewable & Orodispersible Aids, 8 Emulsifying Agents, 6 Surfactant & Foaming Agents, 6 Rheology Modifiers, 5 Lubricants & Glidants, 5 Coloring Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 1 Soft Gelatin

62 Coating Systems & Additives
41 Fillers, Diluents & Binders
35 Controlled & Modified Release
28 Thickeners and Stabilizers
26 Solubilizers
24 Film Formers & Plasticizers
20 Parenteral
20 Topical
17 Taste Masking
17 Direct Compression
14 Granulation
10 Co-Processed Excipients
9 Empty Capsules
9 Disintegrants & Superdisintegrants
8 Chewable & Orodispersible Aids
8 Emulsifying Agents
6 Surfactant & Foaming Agents
6 Rheology Modifiers
5 Lubricants & Glidants
5 Coloring Agents
4 Vegetarian Capsules
4 API Stability Enhancers
1 Soft Gelatin

DIGITAL CONTENT

34 NEWS #PharmaBuzz

34 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 60 Finished Drug Prices, 10 Annual Reports

3 US Medicaid Prescriptions
60 Finished Drug Prices
10 Annual Reports

MARKET PLACE

25 APIs, 3 FDF Dossiers

25 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 3 Others

2 EDQM
2 USP
3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 10,898 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4GlaxoSmithKline Inc.

filter Patent Reset all filters

4 All

01 22170047

02 22171329

filter Product Reset all filters

4 All

01 2Dutasteride

02 2Dutasteride and Tamsulosin hydrochloride

filter Dosage Reset all filters

4 All

01 4Capsule

filter Exp Date Reset all filters

4 All

01 42014-09-16

Product Main Page

01

GlaxoSmithKline Inc.

Dutasteride

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-09-16

Date Granted : 2004-11-09

Dutasteride

Brand Name : AVODART

Patent Number : 2170047

Filing Date : 1994-09-16

Strength per Unit : 0.5 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-09-16

Date Granted : 2004-11-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GlaxoSmithKline Inc.

Dutasteride

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-09-16

Date Granted : 2004-11-23

Dutasteride

Brand Name : AVODART

Patent Number : 2171329

Filing Date : 1994-09-16

Strength per Unit : 0.5 mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-09-16

Date Granted : 2004-11-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GlaxoSmithKline Inc.

Dutasteride

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-09-16

Date Granted : 2004-11-09

Dutasteride

Brand Name : JALYN

Patent Number : 2170047

Filing Date : 1994-09-16

Strength per Unit : 0.5mg/0.4mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-09-16

Date Granted : 2004-11-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

GlaxoSmithKline Inc.

Dutasteride

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-09-16

Date Granted : 2004-11-23

Dutasteride

Brand Name : JALYN

Patent Number : 2171329

Filing Date : 1994-09-16

Strength per Unit : 0.5mg/0.4mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-09-16

Date Granted : 2004-11-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!